Cargando…
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
BACKGROUND: In October 2020, the National Cancer Institute (NCI) Serological Sciences Network (SeroNet) was established to study the immune response to COVID-19, and “to develop, validate, improve, and implement serological testing and associated technologies.” SeroNet is comprised of 25 participati...
Ejemplares similares
-
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
por: Karger, Amy B., et al.
Publicado: (2022) -
Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
por: Figueiredo, Jane C, et al.
Publicado: (2022) -
The SeroNet Clinical and Translational Serology Task Force (CTTF) SARS-CoV-2 mucosal immunity methodological considerations and best practices workshop
por: Hempel, Heidi, et al.
Publicado: (2023) -
The HPV Serology Laboratory leads an initiative to standardize and harmonize human papillomavirus serology assays
por: Park, Isabel, et al.
Publicado: (2023) -
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
por: Sobhani, Kimia, et al.
Publicado: (2023)